| References |
| 1. |
Adrian, T. E.,
S. R., Bloom,
K. Hermansen, and
J. Iversen,
Pancreatic polypeptide glucagon and insulin secretion from isolated perfused canine pancreas.
Diabetologia
14:
413–417,
1978.
|
| 2. |
Ahken, B.,
J., Alumets,
M. Ericson,
J. Fahrenkrug,
L. Fahrenkrug,
R. Håkanson,
P. Hedner,
I. Loren,
A. Melander,
C. Rerup, and
F. Sundler,
VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion.
Nature Lond.
287:
343–345,
1980.
|
| 3. |
Ahren, B.,
R., Håkanson, and
C. Rerup,
VIP‐stimulated thyroid hormone secretion: effects of other neuropeptides and α‐ or β‐adrenoceptor blockade.
Acta Physiol. Scand.
114:
471–473,
1982.
|
| 4. |
Alm, P.,
J., Alumets,
R. Håkanson,
C. Owman,
N.‐O. Sjöberg,
F. Sundler, and
B. Walles,
Origin and distribution of VIP (vasoactive intestinal polypeptide)‐nerves in the genitourinary tract.
Cell Tissue Res.
205:
337–347,
1980.
|
| 5. |
Alm, P.,
J., Alumets,
R. Håkanson, and
F. Sundler,
Peptidergic (vasoactive intestinal peptide) nerves in the genitourinary tract.
Neuroscience
2:
751–754,
1977.
|
| 6. |
Altiere, R. J., and
L. Diamond,
Relaxant effects of vasoactive intestinal peptide and bethanechol in cat intrapulmonary artery.
Eur. J. Pharmacol.
93:
121–124,
1983.
|
| 7. |
Altiere, R. J., and
L. Diamond,
Relaxation of cat tracheobronchial and pulmonary arterial smooth muscle by vasoactive intestinal peptide: lack of influence by peptidase inhibitors.
Br. J. Pharmacol.
82:
321–328,
1984.
|
| 8. |
Alumets, J.,
J., Fahrenkrug,
R. Håkanson,
O. B. Schaffalitzky De Muckadell,
F. Sundler, and
R. Uddman,
A rich VIP nerve supply is characteristic of sphincters.
Nature Lond.
280:
155–156,
1979.
|
| 9. |
Amiranopf, B., and
G. Rosselin,
VIP receptors and control of cyclic AMP production. In:
Vasoactive Intestinal Polypeptides, edited by
S. I. Said.
New York:
Raven,
1982,
p. 307–322.
|
| 10. |
Anagnostides, A. A.,
K., Manolas,
N. D. Christofides,
Y. Yiangou,
R. B. Welbourn,
S. R. Bloom, and
V.S. Chadwick,
Peptide histidine isoleucine (PHI). A secretagogue in porcine intestine.
Dig. Dis. Sci.
28:
893–896,
1983.
|
| 11. |
Andersson, P.‐O.,
S. R., Bloom,
A. V. Edwards,
J. Järhult, and
S. Melander,
Neural vasodilator control in the rectum of the cat and its possible mediation by vasoactive intestinal polypeptide.
J. Physiol. Lond.
344:
49–67,
1983.
|
| 12. |
Andersson, P.‐O.,
S. R., Bloom, and
J. Järhult,
Colonic motor and vascular responses to pelvic nerve stimulation and their relation to local peptide release in the cat.
J. Physiol. Lond.
344:
293–307,
1983.
|
| 13. |
Andersson, P.‐O.,
S. R., Bloom, and
S. Mellander,
Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide.
J. Physiol. Lond.
350:
209–224,
1984.
|
| 14. |
Angel, F.,
V. L. W., Go,
P. F. Schmalz, and
J. H. Szurszewski,
Vasoactive intestinal polypeptide: a putative transmitter in the canine gastric muscularis mucosa.
J. Physiol. Lond.
341:
641–654,
1983.
|
| 15. |
Bataille, D.,
C., Gespach,
M. Laburthe,
B. Amiranoff,
K. Tatemoto,
N. Vauclin,
V. Mutt, and
G. Rosselin,
Porcine peptide having N‐terminal histidine and C‐terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin‐like effects in different tissues from the rat.
FEBS Lett.
114:
240–242,
1980.
|
| 16. |
Behar, J.,
S., Field, and
C. Marin,
Effect of glucagon, secretin and vasoactive intestinal polypeptide on the feline lower esophageal sphincter: mechanism of action.
Gastroenterology
77:
1001–1007,
1979.
|
| 17. |
Beinfeld, M. C.,
D. M., Korchak,
B. L. Roth, and
T. L. O'Donahue,
The distribution and chromatographic characterization of PHI (peptide histidine isoleucine amide)‐27‐like peptide in rat and porcine brain.
J. Neurosci.
11:
2681–2688,
1984.
|
| 18. |
Bevan, J. A.,
M., Moscowitz,
S. I. Said, and
G. Bugas,
Evidence that vasoactive intestinal polypeptide is a dilator transmitter to some cerebral and extracerebral cranial arteries.
Peptides Fayetteville
5:
385–388,
1984.
|
| 19. |
Biancani, P.,
J. H., Walsh, and
J. Behar,
Vasoactive intestinal polypeptide: a neurotransmitter for lower esophageal sphincter relaxation.
J. Clin. Invest.
73:
963–967,
1984.
|
| 20. |
Bishop, A. E.,
J. M., Polak,
I. C. Green,
M. G. Bryant, and
S. R. Bloom,
The location of VIP in the pancreas of man and rat.
Diabetologia
18:
73–78,
1980.
|
| 21. |
Bishop, A. E.,
J. M., Polak,
Y. Yiangou,
N. D. Christofides, and
S. R. Bloom,
The distributions of PHI and VIP in porcine gut and their co‐localization to a proportion of intrinsic ganglion cells.
Peptides NY
5:
255–259,
1984.
|
| 22. |
Bitar, K. N., and
G. M. Makhlouf,
Relaxation of isolated gastric smooth muscle cells by vasoactive intestinal peptide.
Science Wash. DC
216:
531–533,
1982.
|
| 23. |
Bitar, K. N.,
S. I., Said,
G. C. Weir,
B. Saffouri, and
G. M. Makhlouf,
Neural release of vasoactive intestinal peptide from the gut.
Gastroenterology
79:
1288–1294,
1980.
|
| 24. |
Blitz, W., and
G. A. Charbon,
Regional vascular influences of vasoactive intestinal polypeptide.
Scand. J. Gastroenterol.
18:
755–763,
1983.
|
| 25. |
Bloom, S. R.,
N. D., Christofides,
J. Delamarter,
G. Buell,
E. Kawashima, and
J. M. Polak,
Diarrhoea in VIPoma patients associated with cosecretion of a second active peptide (peptide histidine isoleucine) explained by single coding gene.
Lancet
2:
1163–1165,
1983.
|
| 26. |
Bloom, S. R., and
A. V. Ewards,
Effects of autonomic stimulation on the release of vasoactive intestinal peptide from the gastrointestinal tract in the calf.
J. Physiol. Lond.
299:
437–452,
1980.
|
| 27. |
Bodanszky, M.,
A., Bodanszky,
U. S. Klausner, and
S. I. Said,
A preferred conformation in the vasoactive intestinal peptide (VIP). Molecular architecture of gastrointestinal hormones.
Biorg. Chem.
3:
133–140,
1974.
|
| 28. |
Bodanszky, M.,
U. S., Klausner,
C. Y. Lin,
V. Mutt, and
S. I. Said,
Synthesis of the vasoactive intestinal peptide (VIP).
J. Am. Chem. Soc.
96:
4973–4978,
1974.
|
| 29. |
Bryant, M. G.,
S. R., Bloom,
J. M. Polak,
R. H. Albuquerque,
I. Modlin, and
A. G. E. Pearse,
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.
Lancet
1:
991–993,
1976.
|
| 30. |
Burhol, P. G.,
I., Lygren, and
H. L. Waldum,
Radioimmunoassay of vasoactive intestinal polypeptide in plasma.
Scand. J. Gastroenterol.
13:
807–813,
1978.
|
| 31. |
Burleigh, D. E.,
A. D'Mello, and
A. G. Parks,
Responses of isolated human internal anal sphincter to drugs and electrical field stimulation.
Gastroenterology
77:
484–490,
1979.
|
| 32. |
Calam, J.,
R., Dimaline,
W. S. Peart,
J. Singh, and
R. J. Unwin,
Effects of vasoactive intestinal polypeptide on renal function in man.
J. Physiol. Lond.
345:
469–475,
1983.
|
| 33. |
Calam, J.,
R., Dimaline,
W. S. Peart, and
R. Unwin,
Studies on the renin response to vasoactive intestinal polypeptide (VIP) in the conscious rabbit.
Br. J. Pharmacol.
80:
13–15,
1983.
|
| 34. |
Carlquist, M.,
H., Jörnvall,
K. Tatemoto, and
V. Mutt,
A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide.
Gastroenterology
83:
245–249,
1982.
|
| 35. |
Carlquist, M.,
T. J., Mcdonald,
V. L. W. Go,
D. Bataille,
C. Johansson, and
V. Mutt,
Isolation and amino acid composition of human vasoactive intestinal polypeptide (VIP).
Horm. Metab. Res.
14:
28–29,
1982.
|
| 36. |
Carlquist, M.,
V., Mutt, and
H. Jörnvall,
Isolation and characterization of bovine vasoactive intestinal peptide (VIP).
FEBS Lett.
108:
457–460,
1979.
|
| 37. |
Carter, A. M.,
N., Einer‐Jensen,
J. Fahrenkrug, and
B. Ottesen,
Increased myometrial blood flow evoked by vasoactive intestinal polypeptide in the non‐pregnant goat.
J. Physiol. Lond.
310:
471–480,
1981.
|
| 38. |
Chang, T.‐M.,
F. L., Roth,
H.‐H. Thai, and
W. Y. Chey,
Radioimmunoassay of vasoactive intestinal peptide.
Anal. Biochem.
97:
286–297,
1979.
|
| 39. |
Chayvialle, J.‐A.,
M., Miyata,
P. L. Rayford, and
J. C. Thompson,
Effects of test meal, intragastric nutrients and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide in dogs.
Gastroenterology
79:
844–852,
1980.
|
| 40. |
Christofides, N. D.,
Y., Yiangou,
E. Aarons,
G.‐L. Ferri,
K. Tatemoto,
J. M. Polak, and
S. R. Bloom,
Radioimmunoassay and intramural distribution of PHI‐IR in human intestine.
Dig. Dis. Sci.
28:
507–512,
1983.
|
| 41. |
Clark, K. E.,
E. G., Mills,
S. J. Stys, and
A. E. Seeds,
Effects of vasoactive intestinal polypeptide on the uterine vasculature.
Am. J. Obstet. Gynecol.
139:
182–188,
1981.
|
| 42. |
Cocks, T., and
G. Burnstock,
Effects of neuronal polypeptides on intestinal smooth muscle: a comparison with non‐adrenergic, non‐cholinergic nerve stimulation and ATP.
Eur. J. Pharmacol.
54:
408–419,
1979.
|
| 43. |
Cohen, M. L., and
A. S. Landry,
Vasoactive intestinal polypeptide: increased tone, enhancement of acetylcholine release, and stimulation of adenylate cyclase in intestinal smooth muscle.
Life Sci.
26:
811–822,
1980.
|
| 44. |
Costa, M., and
J. B. Furness,
The origins, pathways and terminations of neurons with VIP‐like immunoreactivity in the guinea‐pig small intestine.
Neuroscience
8:
665–676,
1983.
|
| 45. |
Costa, M.,
J. B., Furness,
R. Buffa, and
S. I. Said,
Distribution of enteric neurons showing immunoreactivity for vasoactive intestinal polypeptide (VIP) in the guinea‐pig intestine.
Neuroscience
5:
587–596,
1980.
|
| 46. |
Coupar, I. M.,
Stimulation of sodium and water secretion without inhibition of glucose absorption in the rat jejunum by vasoactive intestinal peptide (VIP).
Clin. Exp. Pharmacol. Physiol.
3:
615–618,
1976.
|
| 47. |
Cox, P.,
M. R., Lerner,
J. H. Wells, and
S. I. Said,
Inhaled vasoactive intestinal peptide (VIP) prevents bronchoconstriction induced by inhaled histamine.
Am. Rev. Respir. Dis.
127:
249,
1983.
|
| 48. |
Dartt, D. A.,
A. K., Baker,
C. Vaillant, and
P. E. Rose,
Vasoactive intestinal polypeptide stimulation of protein secretion from rat lacrimal gland acini.
Am. J. Physiol.
247
(Gastrointest. Liver Physiol. 10):
G502–G509,
1984.
|
| 49. |
De Neef, P.,
P. Robberecht,
P. Chatelain,
M. Waelbroeck, and
J. Christophe,
The in vitro chromotropic and inotropic effects of vasoactive intestinal peptide (VIP) on the atria and ventricular papillary muscle from Cynomolgus monkey heart.
Regul. Pept.
8:
237–244,
1984.
|
| 50. |
Dey, R. D.,
W. A., Shannon, and
S. I. Said,
Localization of VIP‐immunoreactive nerves in airways and pulmonary vessels of dogs, cats and human subjects.
Cell Tissue Res.
220:
231–238,
1981.
|
| 51. |
Diamond, L.,
J. L., Szarek,
M. N. Gillespie, and
R. J. Altiere,
In vivo bronchodilator activity of vasoactive intestinal peptide in the cat.
Am. Rev. Respir. Dis.
128:
827–832,
1983.
|
| 52. |
Dimaline, R., and
G. J. Dockray,
Multiple immunoreactive forms of vasoactive intestinal peptide in human colonic mucosa.
Gastroenterology
75:
387–392,
1978.
|
| 53. |
Dimaline, R., and
G. J. Dockray,
Molecular variants of vasoactive intestinal polypeptide in dog, rat and hog.
Life Sci.
25:
1893–1900,
1979.
|
| 54. |
Dimaline, R., and
G. J. Dockray,
Actions of a new peptide from porcine intestine (PHI) on pancreatic secretion in the rat and turkey.
Life Sci.
27:
1947–1951,
1980.
|
| 55. |
Dimaline, R.,
W. S., Peart, and
R. J. Unwin,
Effects of vasoactive intestinal polypeptide (VIP) on renal function and plasma renin activity in the conscious rabbit.
J. Physiol. Lond.
344:
379–388,
1983.
|
| 56. |
Dimaline, R.,
J. R., Reeve,
J. E. Shively, and
D. Hawke,
Isolation and characterization of rat vasoactive intestinal peptide.
Peptides NY
5:
183–187,
1984.
|
| 57. |
Dimaline, R.,
C., Vaillant, and
G. J. Dockray,
The use of region‐specific antibodies in the characterization and localization of vasoactive intestinal polypeptide‐like substances in the rat gastrointestinal tract.
Regul. Pept.
1:
1–16,
1980.
|
| 58. |
Domschke, S.,
W., Domschke,
S. R. Bloom,
P. Metznegg,
S. J. Mitchell,
G. Lux, and
U. Strunz,
Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effect.
Gut
19:
1049–1053,
1978.
|
| 59. |
Domschke, S.,
W., Domschke,
D. Wolfram,
W. Rosch,
S. J. Konturek,
W. Sprugel,
P. Mitznegg,
E. Wünsch, and
L. Demling,
Vasoactive intestinal polypeptide: a secretin‐like partial agonist for pancreatic secretion in man.
Gastroenterology
73:
478–480,
1977.
|
| 60. |
Domschke, W.,
G., Lux,
S. Domschke,
U. Strunz,
S. R. Bloom, and
E. Wünsch,
Effects of vasoactive intestinal peptide on resting and pentagastrin‐stimulated lower esophageal sphincter pressure.
Gastroenterology
75:
9–12,
1978.
|
| 61. |
Du, B.‐H.,
J., Eng,
J. D. Hulmes,
M. Chang,
Y.‐C. E. Pan, and
R. S. Yalow,
Guinea pig has a unique mammalian VIP.
Biochem. Biophys. Res. Commun.
128:
1093–1098,
1985.
|
| 62. |
Ebeid, A. M.,
P., Murray,
H. Hirsch,
R. I. C. Wesdorp, and
J. E. Fischer,
Radioimmunoassay of vasoactive intestinal peptide.
J. Surg. Res.
20:
355–360,
1976.
|
| 63. |
Ebeid, A. M.,
P., Murray,
P. B. Soeters, and
J. E. Fischer,
Release of VIP by calcium stimulation.
Am. J. Surg.
133:
140–144,
1977.
|
| 64. |
Eckenstein, F., and
R. W. Baughman,
Two types of cholinergic innervation in cortex, one co‐localized with vasoactive intestinal polypeptide.
Nature Lond.
309:
153–155,
1984.
|
| 65. |
Edin, R.,
J. M., Lundberg,
H. Ahlman,
A. Dahlström,
J. Fahrenkrug,
T. Hökfelt, and
J. Kewenter,
On the VIPergic innervation of the feline pylorus.
Acta Physiol. Scand.
107:
185–187,
1979.
|
| 66. |
Edvinsson, L.,
J., Fahrenkrug,
J. Hanko,
C. Owman,
F. Sundler, and
R. Uddman,
VIP (vasoactive intestinal polypeptide)‐containing nerves of intracranial arteries in mammals.
Cell Tissue Res.
208:
135–142,
1980.
|
| 67. |
Eklund, S.,
J., Fahrenkrug,
M. Jodal,
O. Lundgren,
O. B. Schaffalitzky De Muckadell, and
A. Sjoqvist,
Vasoactive intestinal polypeptide, 5‐hydroxytryptamine and reflex hyperaemia in the small intestine of the cat.
J. Physiol. Lond.
302:
549–557,
1980.
|
| 68. |
Eklund, S.,
M., Jodal,
O. Lundgren, and
A. Sjoqvist,
Effects of vasoactive intestinal polypeptide on blood flow, motility and fluid transport in the gastrointestinal tract of the cat.
Acta Physiol. Scand.
105:
461–468,
1979.
|
| 69. |
Emson, P. C.,
J., Fahrenkrug,
O. B. Schaffalitzky De Muckadell,
T. M. Jessel, and
L. L. Iversen,
Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium‐evoked release from rat hypothalamus.
Brain Res.
143:
174–178,
1978.
|
| 70. |
Fahrenkrug, J.,
Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function.
Digestion
19:
149–169,
1979.
|
| 71. |
Fahrenkrug, J.,
Evidence for common precursors but differential processing of VIP and PHM in VIP‐producing tumors.
Peptides NY
6:
357–361,
1985.
|
| 72. |
Fahrenkrug, J.,
T., Bek,
J. M. Lundberg, and
T. Hökfelt,
VIP and PHI in cat neurons: colocalization but variable tissue content possibly due to differential processing.
Regul. Pept.
12:
21–34,
1985.
|
| 73. |
Fahrenkrug, J.,
H., Galbo,
J. J. Holst, and
O. B. Schaffalitzky De Muckadell,
Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract.
J. Physiol. Lond.
280:
405–422,
1978.
|
| 74. |
Fahrenkrug, J.,
U., Haglund,
M. Jodal,
O. Lundgren,
L. Olbe, and
O. B. Schaffalitzky De Muckadell,
Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: possible physiological implications.
J. Physiol. Lond.
284:
291–305,
1978.
|
| 75. |
Fahrenkrug, J., and
B. Ottesen,
Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics.
J. Physiol. Lond.
331:
451–460,
1982.
|
| 76. |
Fahrenkrug, J., and
J. H. Pedersen,
Development and validation of a specific radioimmunoassay for PHI in plasma.
Clin. Chim. Acta
143:
183–192,
1984.
|
| 77. |
Fahrenkrug, J., and
O. B. Schaffalitzky De Muckadell,
Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.
J. Lab. Clin. Med.
89:
1379–1388,
1977.
|
| 78. |
Fahrenkrug, J.,
O. B. Schaffalitzky De Muckadell,
J. J. Holst, and
Sl. L. Jensen,
Vasoactive intestinal polypeptide in vagally mediated pancreatic secretion of fluid and bicarbonate.
Am. J. Physiol.
237
(Endocrinol. Metab. Gastrointest. Physiol. 6):
E535–E540,
1979.
|
| 79. |
Feher, E., and
C. Leranth,
Light and electron microscopic immunocytochemical localization of vasoactive intestinal polypeptide VIP‐like activity in the rat small intestine.
Neuroscience
10:
97–106,
1083.
|
| 80. |
Ferri, G. L.,
P., Botti,
G. Biliotti,
L. Rebecchi,
S. R. Bloom,
L. Tonelli,
G. Labo, and
J. M. Polak,
VIP‐, substance P‐and Met‐enkephalin‐immunoreactive innervation of the human gastroduodenal mucosa and Brunner's glands.
Gut
25:
948–952,
1984.
|
| 81. |
Frandsen, E. K., and
A. J. Moody,
Lipolytic action of a newly isolated vasoactive intestinal polypeptide.
Horm. Metab. Res.
5:
196–199,
1973.
|
| 82. |
Furness, J. B., and
M. Costa,
Projections of intestinal neurons showing immunoreactivity of vasoactive intestinal polypeptide are consistent with these neurons being the enteric inhibitory neurons.
Neurosci. Lett.
15:
199–204,
1979.
|
| 83. |
Furness, J. B.,
M., Costa, and
J. H. Walsh,
Evidence for and significance of the projection of VIP neurons from the myenteric plexus to the taenia coli in the guinea pig.
Gastroenterology
80:
1557–1561,
1981.
|
| 84. |
Fuxe, K.,
T., Hokfelt,
S. I. Said, and
V. Mutt,
Vasoactive intestinal polypeptide and the nervous system: immunohistochemical evidence for localization in central and peripheral neurons, particularly intracortical neurons of the cerebral cortex.
Neurosci. Lett.
5:
241–246,
1977.
|
| 85. |
Gaginella, T. S.,
T., O'Dorisio, and
K. A. Hughel,
Release of vasoactive intestinal polypeptide by electrical field stimulation of rabbit ileum.
Regul. Pept.
2:
165–174,
1981.
|
| 86. |
Giachetti, A., and
S. I. Said,
Axonal transport of vasoactive intestinal peptide in sciatic nerve.
Nature Lond.
281:
574–575,
1979.
|
| 87. |
Giachetti, A.,
S. I., Said,
R. C. Reynolds, and
F. C. Koniges,
Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals.
Proc. Natl. Acad. Sci. USA
74:
3424–3428,
1977.
|
| 88. |
Gibbins, I. L.,
J. E., Brayden, and
J. A. Bevan,
Perivascular nerves with immunoreactivity to vasoactive intestinal polypeptide in cephalic arteries of the cat: distribution, possible origins and functional implications.
Neuroscience
13:
1327–1346,
1984.
|
| 89. |
Gilbert, R. F. T.,
P. C., Emson,
J. Fahrenkrug,
C. M. Lee,
E. Penman, and
J. Wass,
Axonal transport of neuropeptides in the cervical vagus nerve of the rat.
J. Neurochem.
34:
108–113,
1980.
|
| 90. |
Goyal, R. K.,
S., Rattan, and
S. I. Said,
VIP as a possible neurotransmitter of non‐cholinergic, non‐adrenergic inhibitory neurones.
Nature Lond.
288:
378–380,
1980.
|
| 91. |
Gozes, I.,
N., Bodner,
Y. Schani, and
M. Fridkin,
Detection of mRNAs containing regulatory peptides coding sequences using synthetic oligodeoxynucleotides.
J. Cell. Biochem.
26:
147–156,
1984.
|
| 92. |
Grider, J. R.,
M. B., Cable,
H. N. Bitar,
S. I. Said, and
G. M. Makhlouf,
Vasoactive intestinal peptide: relexant neurotransmitter in taenia coli of the guinea pig.
Gastroenterology
89:
36–42,
1985.
|
| 93. |
Grider, J. R.,
B., Cable,
S. I. Said, and
G. M. Makhlouf,
Vasoactive intestinal peptide as neural mediator of gastric relaxation.
Am. J. Physiol.
248
(Gastrointest. Liver Physiol. 11):
G73–G78,
1985.
|
| 94. |
Gu, J.,
M. A., Blank,
W. M. Huang,
K. N. Islam,
G. P. Mcgregor,
N. Christofides,
J. M. Allen,
S. R. Bloom, and
J. M. Polak,
Peptide‐containing nerves in the human urinary bladder.
Urology
24:
353–357,
1984.
|
| 95. |
Gu, J.,
J. M., Polak,
L. Probert,
K. N. Islam,
P. J. Marangos,
S. Mina,
T. E. Adrian,
G. P. Mcgregor,
D. J. O'Shaugh‐Nessy, and
S. R. Bloom,
Peptidergic innervation of the human male genital tract.
J. Urol.
130:
386–391,
1983.
|
| 96. |
Hamasaki, Y.,
M., Mojarad, and
S. I. Said,
Relaxant action of VIP on cat pulmonary artery: comparison with acetylcholine, isoproterenol, and PGE1.
J. Appl. Physiol.
54:
1607–1611,
1983.
|
| 97. |
Hand, J. H.,
R. B., Laravuso, and
J. A. Will,
Relaxation of isolated guinea pig trachea, bronchi and pulmonary arteries produced by vasoactive intestinal peptide (VIP).
Eur. J. Pharmacol.
98:
279–284,
1984.
|
| 98. |
Hansen, B.,
B. Ottesen,
J. J. Larsen, and
J. Fahrenkrug,
Neurotransmitter‐role of VIP in non‐adrenergic relaxation of feline myometrium.
Peptides NY
7,
Suppl. 1:
201–203,
1986.
|
| 99. |
Heistad, D. D.,
M. L., Marcus,
S. I. Said, and
P. M. Gross,
Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow.
Am. J. Physiol.
239
(Heart Circ. Physiol. 8):
H73–H80,
1980.
|
| 100. |
Helm, G.,
B., Ottesen,
J. Fahrenkrug,
J.‐J. Larsen,
C. Owman,
N.‐O. Sjöberg,
B. Stolberg,
F. Sundler, and
B. Walles,
Vasoactive intestinal polypeptide (VIP) in the human female reproductive tract: distribution and motor effects.
Biol. Reprod.
25:
227–234,
1981.
|
| 101. |
Hökfelt, T.,
L.‐G., Elfvin,
M. Schultzberg,
K. Fuxe,
S. I. Said,
V. Mutt, and
M. Goldstein,
Immunohistochemical evidence of vasoactive intestinal polypeptide‐containing neurons and nerve fibres in sympathetic ganglia.
Neuroscience
2:
885–896,
1977.
|
| 102. |
Hökfelt, T.,
J., Fahrenkrug,
K. Tatemoto,
V. Mutt, and
S. Werner,
PHI, a VIP‐like peptide, is present in the rat median eminence.
Acta Physiol. Scand.
116:
469–471,
1982.
|
| 103. |
Hökfelt, T.,
J., Fahrenkrug,
K. Tatemoto,
V. Mutt,
S. Werner,
A.‐L. Hulting,
L. Terenius, and
K. J. Chang,
The PHI (PHI‐27)/corticotropin‐releasing factor/enkephalin immunoreactive hypothalamic neurons: possible morphological basis for integrated control of prolactin, corticotropin and growth hormone secretion.
Proc. Natl. Acad. Sci. USA
80:
895–898,
1983.
|
| 104. |
Hökfelt, T.,
J. M., Lundberg,
M. Schultzberg, and
J. Fahrenkrug,
Immunohistochemical evidence for a local VIP‐ergic neuron system in the adrenal gland of the rat.
Acta Physiol. Scand.
113:
575–576,
1981.
|
| 105. |
Hölliger, C.,
M., Radzyner, and
M. Knoblauch,
Effects of glucagon, vasoactive intestinal peptide, and vasopressin in villous microcirculation and superior mesenteric artery blood flow of the rat.
Gastroenterology
85:
1036–1043,
1983.
|
| 106. |
Holst, J. J.,
J., Fahrenkrug,
S. Knuhtsen,
S. L. Jensen,
O. V. Nielsen,
J. M. Lundberg, and
T. Hökfelt,
VIP and PHI in the pig pancreas: coexistence, corelease, and cooperative effects.
Am. J. Physiol.
252
(Gastrointest. Liver Physiol. 15):
G182–G189,
1987.
|
| 107. |
Holst, J. J.,
J., Fahrenkrug,
S. Knuhtsen,
S. L. Jensen,
S. S. Poulsen, and
O. V. Nielsen,
Vasoactive intestinal polypeptide (VIP) in the pig pancreas: role of VIPergic nerves in control of fluid and bicarbonate secretion.
Regul. Pept.
8:
245–259,
1984.
|
| 108. |
Holzwarth, M. A.,
The distribution of vasoactive intestinal peptide in the rat adrenal cortex and medulla.
J. Autonom. Nerv. Syst.
11:
269–283,
1984.
|
| 109. |
Inoue, H.,
S., Shiosaka,
Y. Sasaki,
N. Hayashi,
N. Satoh,
T. Kamata,
M. Tokyama, and
Y. Shiotani,
Three‐dimensional distribution of vasoactive intestinal polypeptide‐containing structures in the rat stomach and their origins using whole mount tissue.
J. Neural Transm.
59:
195–205,
1984.
|
| 110. |
Ipp, E.,
R. E., Dibbs, and
R. H. Unger,
Vasoactive intestinal peptide stimulates pancreatic somatostatin release.
FEBS Lett.
90:
76–78,
1978.
|
| 111. |
Itakura, T.,
T., Okuno,
K. Nakakita,
I. Kamei,
Y. Naka,
K. Nakai,
H. Imai,
N. Komai,
H. Kimura, and
T. Mada,
A light and electron microscopic immunohistochemical study of vasoactive intestinal polypeptide and substance P‐containing nerve fibers along the cerebral blood vessels. Comparison with aminergic and cholinergic nerve fibers.
J. Cerebr. Blood Flow Metab.
4:
407–414,
1984.
|
| 112. |
Itoh, N.,
K., Obata,
N. Yanaihara, and
H. Okamoto,
Human preprovasoactive intestinal polypeptide contains a novel PHI‐27‐like peptide, PHM‐27.
Nature Lond.
304:
547–549,
1983.
|
| 113. |
Jaffer, S. S.,
J. T., Farrar,
W. M. Yau, and
G. M. Makhlouf,
Mode of action and interplay of vasoactive intestinal peptide (VIP), secretin and octapeptide of cholecystokinin (OCTA‐CCK) on duodenal and ileal muscle in vitro (Abstract).
Gastroenterology
66:
716,
1974.
|
| 114. |
Jansson, R.,
G., Steen, and
J. Svanvik,
Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat.
Gastroenterology
75:
47–50,
1978.
|
| 115. |
Järhult, J.,
P., Hellstrand, and
F. Sundler,
Immunohistochemical localization and vascular effects of vasoactive intestinal polypeptide in skeletal muscle of the cat.
Cell Tissue Res.
207:
55–64,
1980.
|
| 116. |
Jensen, S. L.,
J., Fahrenkrug,
J. J. Holst,
O. V. Nielsen, and
O. B. Schaffalitzky De Muckadell,
Secretory effects of VIP in isolated perfused porcine pancreas.
Am. J. Physiol.
235:
(Endocrinol. Metab. Gastrointest. Physiol. 4): E387–E391,
1978.
|
| 117. |
Jessen, K. R.,
J. M., Polak,
S. Van Noorden,
S. R. Bloom, and
G. Burnstock,
Peptide‐containing neurons connect the two ganglionated plexuses of the enteric nervous system.
Nature Lond.
283:
391–393,
1980.
|
| 118. |
Jessen, K. R.,
M. J., Saffrey,
S. Van Noorden,
S. R. Bloom,
J. M. Polak, and
G. Burnstock,
Immunohistochemical studies of the enteric nervous system in tissue culture and in situ: localization of vasoactive intestinal polypeptide (VIP), substance‐P and enkephalin immunoreactive nerves in the guinea‐pig gut.
Neuroscience
5:
1717–1735,
1980.
|
| 119. |
Johansson, O., and
J. M. Lundberg,
Ultrastructural localization of VIP‐like immunoreactivity in large dense‐core vesicles of “cholinergic‐type” nerve terminals in cat exocrine glands.
Neuroscience
6:
847–862,
1981.
|
| 120. |
Johns, A.,
The effect of vasoactive intestinal polypeptide on the urinary bladder and taenia coli of the guinea‐pig.
Can. J. Physiol. Pharmacol.
57:
106–108,
1979.
|
| 121. |
Kachelhoffer, J.,
C., Mendel,
J. Dauchel,
D. Hahmatter, and
J. F. Grenier,
The effects of VIP on intestinal motility, a study on ex vivo perfused isolated canine jejunal loops.
Am. J. Dig. Dis.
21:
957–962,
1976.
|
| 122. |
Kawatani, M.,
I. P., Lowe,
I. Nadelhaft,
C. Morgan, and
W. C. De Groat,
Vasoactive intestinal polypeptide in visceral afferent pathways to the sacral spinal cord of the cat.
Neurosci. Lett.
42:
311–316,
1983.
|
| 123. |
Kerins, C., and
S. I. Said,
Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide.
Proc. Soc. Exp. Biol. Med.
142:
1014–1017,
1973.
|
| 124. |
Kinder, R. B., and
A. R. Mundy,
Inhibition of spontaneous contractile activity in isolated human detrusor muscle strips by vasoactive intestinal polypeptide.
Br. J. Urol.
57:
20–23,
1985.
|
| 125. |
Kirkegaard, P.,
J. M., Lundberg,
S. S. Poulsen,
P. S. Olsen,
J. Fahrenkrug,
T. Hökfelt, and
J. Christiansen,
Vasoactive intestinal polypeptide nerves and Brunner's gland secretion in the rat.
Gastroenterology
81:
872–878,
1981.
|
| 126. |
Kirkegaard, P.,
P. S., Olsen,
E. Nexø,
J. J. Holst, and
S. S. Poulsen,
Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands.
Gut
25:
1225–1229,
1984.
|
| 127. |
Klarskov, P.,
T., Gerstenberg, and
T. Hald,
Vasoactive intestinal polypeptide influence on lower urinary tract smooth muscle from human and pig.
J. Urol.
131:
1000–1004,
1984.
|
| 128. |
Kobayashi, S.,
K., Kyoshima,
J. A. Olschowka, and
D. M. Jacobowitz,
Vasoactive intestinal polypeptide immunoreactive and cholinergic nerves in the whole mount preparation of the major cerebral arteries of the rat.
Histochemistry
79:
377–381,
1983.
|
| 129. |
Kondo, H.,
H., Kuramoto,
B. H. Wainer, and
N. Yanaihara,
Discrete distribution of cholinergic and vasoactive intestinal polypeptidergic amacrine cells in the rat retina.
Neurosci. Lett.
54:
213–218,
1985.
|
| 130. |
Konturek, S. J.,
P., Thor,
A. Dembinski, and
R. Krol,
Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs.
Gastroenterology
68:
1527–1535,
1975.
|
| 131. |
Konturek, S. J.,
P., Thor,
A. Dembinski, and
R. Krol,
Comparison of pancreatic responses of portal and systemic secretin and VIP in cats.
Am. J. Physiol.
232
(Endocrinol. Metab. Gastrointest. Physiol. 1):
E156–E158,
1977.
|
| 132. |
Kowal, J.,
VIP effects on adrenocortical cell functions. In:
Vasoactive Intestinal Peptide, edited by
S. I. Said.
New York:
Raven,
1982,
p. 227–284.
|
| 133. |
Krejs, G. J.,
R. M., Barkley,
N. W. Read, and
J. S. Fordtran,
Intestinal secretion induced by vasoactive intestinal polypeptide.
J. Clin. Invest.
61:
1337–1345,
1978.
|
| 134. |
Krejs, G. J., and
J. S. Fordtran,
Effect of VIP infusion on water and ion transport in the human jejunum.
Gastroenterology
78:
722–727,
1980.
|
| 135. |
Kulik, T. J.,
D. E., Johnson,
R. P. Elde, and
J. A. Lock,
Pulmonary vascular effects of vasoactive intestinal peptide on conscious newborn lambs.
Am. J. Physiol.
246
(Heart Circ. Physiol. 15):
H716–H719,
1984.
|
| 136. |
Kuo, D. C.,
M., Kawatani, and
W. C. De Groat,
Vasoactive intestinal polypeptide identified in the thoracic dorsal root ganglia of the cat.
Brain Res.
330:
178–182,
1985.
|
| 137. |
Kuwahara,
A. T. Ishikawa,
S. Mikami, and
N. Yanaihara,
Distribution of neurons containing immunoreactivity for gastrin‐releasing peptides (GRP), substance P, and vasoactive intestinal polypeptide (VIP) in the rat gastric wall.
Biomed. Res.
4:
473–478,
1983.
|
| 138. |
Larsen, J.‐J.,
V., Boeck, and
B. Ottesen,
Effect of vasoactive intestinal polypeptide on cerebral blood flow in the goat.
Acta Physiol. Scand.
111:
471–474,
1981.
|
| 139. |
Larsen, J. J.,
B., Ottesen,
J. Fahrenkrug, and
L. Fahrenkrug,
Vasoactive intestinal polypeptide (VIP) in the male genitourinary tract: concentration and motor effect.
Invest. Urol.
19:
211–213,
1981.
|
| 140. |
Larsson, L.‐I,
Ultrastructural localization of a new neuronal peptide (VIP).
Histochemistry
54:
173–176,
1977.
|
| 141. |
Larsson, L.‐I.,
L., Edvinsson,
J. Fahrenkrug,
R. Håkanson,
C. Owman,
O. B. Schaffalitzky De Muckadell, and
F. Sundler,
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves.
Brain Res.
113:
400–404,
1976.
|
| 142. |
Larsson, L.‐I.,
J., Fahrenkrug,
J. J. Holst, and
O. B. Schaffalitzky De Muckadell,
Innervation of the pancreas by vasoactive intestinal polypeptide (VIP) immunoreactive nerves.
Life Sci.
22:
773–780,
1978.
|
| 143. |
Larsson, L.‐I.,
J., Fahrenkrug, and
O. B. Schaffalitzky De Muckadell,
Vasoactive intestinal polypeptide occurs in nerves of the female genitourinary tract.
Science Wash. DC
197:
1374–1375,
1977.
|
| 144. |
Larsson, L.‐I.,
J., Fahrenkrug, and
O. B. Schaffalitzky De Muckadell,
Occurrence of nerves containing vasoactive intestinal polypeptide immunoreactivity in the male genital tract.
Life Sci.
21:
503–508,
1977.
|
| 145. |
Larsson, L.‐I.,
J., Fahrenkrug,
O. Schaffalitzky De Muckadell,
F. Sundler,
R. Håkanson, and
J. Rehfeld,
Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons.
Proc. Natl. Acad. Sci. USA
73:
3197–3200,
1976.
|
| 146. |
Larsson, L.‐I.,
J. M., Polak,
R. Buffa,
F. Sundler, and
E. Solcia,
On the immunocytochemical localization of the vasoactive intestinal polypeptide.
J. Histochem. Cytochem.
27:
936–938,
1979.
|
| 147. |
Leander, S.,
R., Håkanson, and
F. Sundler,
Nerves containing substance P, vasoactive intestinal polypeptide, enkephalin or somatostatin in the guinea‐pig taenia coli. Distribution, ultrastructure and possible functions.
Cell Tissue Res.
215:
21–29,
1981.
|
| 148. |
Lee, T. J.‐F.,
A., Saito, and
I. Berezin,
Vasoactive intestinal polypeptide‐like substance: the potential transmitter for cerebral vasodilation.
Science Wash. DC
224:
898–900,
1984.
|
| 149. |
Lindvall, M.,
J., Alumets,
L. Edvinsson,
J. Fahrenkrug,
R. Håkanson,
J. Hanko,
C. Owman,
O. B. Schaffalitzky De Muckadell, and
F. Sundler,
Peptidergic nerves in the mammalian choroid plexus.
Neurosci. Lett.
9:
77–82,
1978.
|
| 150. |
Linnoila, R. I.,
R. P., Diaugustine,
A. Hervonon, and
R. J. Miller,
Distribution of (Met5)‐ and (Leu5)‐enkephalin‐, vasoactive intestinal polypeptide‐ and substance P‐like immunoreactivity in human adrenal glands.
Neuroscience
5:
2247–2259,
1980.
|
| 151. |
Loren, I.,
K., Tornqvist, and
J. Alumets,
VIP (vasoactive intestinal polypeptide)‐immunoreactive neurons in the retina of the rat.
Cell Tissue Res.
210:
167–170,
1980.
|
| 152. |
Lundberg, J. M.,
A. Ånggård,
P. Emson,
J. Fahrenkrug, and
T. Hökfelt,
VIPergic and cholinergic mechanisms in the cat nasal mucosa: studies on choline‐acetyltransferase and release of VIP.
Proc. Natl. Acad. Sci. USA
78:
5255–5259,
1981.
|
| 153. |
Lundberg, J. M.,
A. Änggård, and
J. Fahrenkrug,
Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine from cat submandibular gland blood flow and secretion. I. VIP release.
Acta Physiol. Scand.
113:
317–327,
1981.
|
| 154. |
Lundberg, J. M.,
A. Änggård, and
J. Fahrenkrug,
Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum.
Acta Physiol. Scand.
113:
329–336,
1981.
|
| 155. |
Lundberg, J. M.,
A. Änggård, and
J. Fahrenkrug,
Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. III. Effects of local infusions.
Acta Physiol. Scand.
114:
329–337,
1982.
|
| 156. |
Lundberg, J. M.,
A. Änggård,
J. Fahrenkrug,
T. Hökfelt, and
V. Mutt,
Vasoactive intestinal polypeptide (VIP) in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion.
Proc. Natl. Acad. Sci. USA
77:
1651–1655,
1980.
|
| 157. |
Lundberg, J. M.,
A. Änggård,
J. Fahrenkrug,
G. Lundgren, and
B. Holmstedt,
Corelease of VIP and acetylcholine in relation to blood flow and salivary secretion in cat submandibular salivary gland.
Acta Physiol. Scand.
115:
525–528,
1982.
|
| 158. |
Lundberg, J. M.,
J., Fahrenkrug, and
S. Brimijoin,
Characteristics of the axonal transport of vasoactive intestinal polypeptide (VIP) in nerves of the cat.
Acta Physiol. Scand.
112:
427–436,
1981.
|
| 159. |
Lundberg, J. M.,
J., Fahrenkrug,
T. Hökfelt,
C.‐R. Martling,
O. Larsson,
K. Tatemoto, and
A. Änggård,
Co‐existence of peptide HI (PHI) and VIP in nervous regulating blood flow and bronchial smooth muscle tone in various mammals including man.
Peptides Fayetteville
5:
593–606,
1984.
|
| 160. |
Lundberg, J. M.,
J., Fahrenkrug,
O. Larsson, and
A. Änggård,
Co‐release of VIP and PHI in relation to atropine resistant vasodilation in cat submandibular salivary gland.
Neurosci. Lett.
52:
37–42,
1984.
|
| 161. |
Lundberg, J. M.,
G., Fried,
J. Fahrenkrug,
B. Holmstedt,
T. Hökfelt,
H. Lagercrantz,
G. Lundgren, and
A. Änggård,
Subcellular fractionation of cat submandibular gland: comparative studies on the distribution of acetylcholine and vasoactive intestinal polypeptide (VIP).
Neuroscience
6:
1001–1010,
1981.
|
| 162. |
Lundberg, J. M.,
T. Hökfelt,
A. Änggård,
K. Uvnäs‐Wallensten,
S. Brimijoin,
E. Brodin, and
J. Fahrenkrug,
Peripheral peptide neurons: distribution, axonal transport and some aspects on possible function. In:
Neural Peptides and Neuronal Communication, edited by
E. Costa and
M. Trabucci.
New York:
Raven,
1980,
p. 25–36.
|
| 163. |
Lundberg, J. M.,
T., Hökfelt,
M. Schultzberg,
K. Uvnäs‐Wallensten,
C. Köhler, and
S. I. Said,
Occurrence of vasoactive intestinal polypeptide (VIP)‐like immunoreactivity in certain cholinergic neurons of the cat. Evidence from combined immunohistochemistry and acetylcholinesterase‐staining.
Neuroscience
4:
1539–1559,
1979.
|
| 164. |
Lundberg, J. M., and
K. Tatemoto,
vascular effects of the peptides PYY and PHI: comparison with APP and VIP.
Eur. J. Pharmacol.
83:
143–146,
1982.
|
| 165. |
Lynch, E. M.,
J., Wharton,
M. G. Bryant,
S. R. Bloom,
J. M. Polak, and
M. G. Elder,
The differential distribution of vasoactive intestinal polypeptide in the normal human female genital tract.
Histochemistry
67:
169–177,
1980.
|
| 166. |
Magnusson, I. H., and
L. Thulin,
Effect of substance P on CCK‐ or VIP‐induced choleresis in anesthetized dogs.
Acta Physiol. Scand.
106:
293–297,
1979.
|
| 167. |
Mailman, D.,
Effects of vasoactive intestinal polypeptide on intestinal absorption and blood flow.
J. Physiol. Lond.
279:
121–123,
1978.
|
| 168. |
Makhlouf, G. M.,
W. M., Yau,
A. M. Zfass,
S. I. Said, and
M. Bodanszky,
Comparative effects of synthetic and natural vasoactive intestinal peptide on pancreatic and biliary secretion and on glucose and insulin blood levels in the dog.
Scand. J. Gastroenterol.
13:
759–765,
1978.
|
| 169. |
Makhlouf, G. M.,
A. M., Zfass,
S. I. Said, and
M. Schebalin,
Effects of synthetic vasoactive intestinal peptide (VIP), secretin and their partial sequences on gastric secretion.
Proc. Soc. Exp. Biol. Med.
157:
565–568,
1978.
|
| 170. |
Malm, L.,
F., Sundler, and
R. Uddman,
Effects of vasoactive intestinal polypeptide on resistance and capacitance vessels in the nasal mucosa.
Acta Otolaryngol.
90:
304–308,
1980.
|
| 171. |
Malmfors, G.,
S., Leander,
E. Brodin,
R. Håkanson,
T. Holmin, and
F. Sundler,
Peptide‐containing neurons intrinsic to the gut wall. An experimental study in the pig.
Cell Tissue Res.
214:
225–238,
1981.
|
| 172. |
Marie, J. C.,
C., Boissard, and
G. Rosselin,
Purification of monoiodinated vasoactive intestinal peptide (M1251‐VIP) by high pressure liquid chromatography (HPLC).
Peptides Fayetteville
5:
179–182,
1984.
|
| 173. |
Matsumura, M.,
H., Akiyoshi, and
S. Fujii,
Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.
J. Biochem.
82:
1073–1076,
1977.
|
| 174. |
Matsuyama, T.,
S., Shiobaka,
M. Matsumoto,
S. Yoneda,
K. Kimura,
H. Abe,
T. Hayakawa,
H. Inoue, and
M. Tohyama,
Overall distribution of vasoactive intestinal polypeptide‐containing nerves on the wall of cerebral arteries: an immunohistochemical study using whole‐mounts.
Neuroscience
10:
89–96,
1983.
|
| 175. |
Matsuzaki, Y.,
Y., Hamasaki, and
S. I. Said,
Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways.
Science Wash. DC
210:
1252–1253,
1980.
|
| 176. |
Mcculloch, J., and
L. Edvinsson,
Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide.
Am. J. Physiol.
238
(Heart Circ. Physiol. 7):
H449–H456,
1980.
|
| 177. |
Mitchell, S. J., and
S. R. Bloom,
Measurement of fasting and postprandial VIP in man.
Gut
19:
1043–1047,
1978.
|
| 178. |
Modlin, I. M.,
S. R., Bloom, and
S. Mitchell,
Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia.
Experientia Basel
34:
535–536,
1978.
|
| 179. |
Morel, G.,
J., Besson,
G. Rosselin, and
P. M. Dubois,
Ultrastructural evidence for endogenous vasoactive intestinal peptide‐like immunoreactivity in the pituitary gland.
Neuroendocrinology
34:
85–89,
1982.
|
| 180. |
Morgan, K. G.,
P. F., Schmalz, and
J. H. Szurszewski,
The inhibitory effects of vasoactive intestinal polypeptide on the mechanical and electrical activity of canine antral smooth muscle.
J. Physiol. Lond.
288:
437–450,
1978.
|
| 181. |
Morice, A.,
R. J., Unwin, and
P. S. Sever,
Vasoactive intestinal peptide causes bronchodilatation and protects against histamine‐induced bronchoconstriction in asthmatic subjects.
Lancet
2:
1225–1226,
1983.
|
| 182. |
Mutt, V.,
Preparation of highly purified secretin.
Ark. Kemi
15:
69–74,
1959.
|
| 183. |
Mutt, V., and
S. I. Said,
Structure of the porcine vasoactive intestinal octacosapeptide. The amino‐acid sequence. Use of kallikrein in its determination.
Eur. J. Biochem.
42:
581–589,
1974.
|
| 184. |
Nikkinen, A.,
J. I., Lethosalo,
H. Uusitalo,
A. Palkama, and
P. Panula,
The lacrimal glands of the rat and the guinea‐pig are innervated by fibres containing immunoreactivities for substance P and vasoactive intestinal polypeptide.
Histochemistry
81:
23–27,
1984.
|
| 185. |
Nilsson, A.,
Isolation, amino acid composition and terminal amino acid residues of the vasoactive octacosapeptide from chicken intestine. Partial purification of chicken secretin.
FEBS Lett.
47:
284–289,
1974.
|
| 186. |
Nilsson, A.,
Structure of the vasoactive intestinal octacosapeptide from chicken intestine. The amino acid sequence.
FEBS Lett.
60:
322–326,
1975.
|
| 187. |
Nilsson, S. F. E., and
A. Bill,
Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows.
Acta Physiol. Scand.
121:
385–392,
1984.
|
| 188. |
Nishizawa, M.,
Y., Hayakawa,
M. Yanaihara, and
H. Okamoto,
Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat.
FEBS Leu.
183:
55–59,
1985.
|
| 189. |
Ottesen, B., and
N. Einer‐Jensen,
Increased endometrial clearance of 85krypton evoked by VIP in rabbits.
Acta Physiol. Scand.
121:
185–187,
1984.
|
| 190. |
Ottesen, B., and
J. Fahrenkrug,
Effect of vasoactive intestinal polypeptide (VIP) upon myometrial blood flow in non‐pregnant rabbit.
Acta Physiol. Scand.
112:
195–201,
1981.
|
| 191. |
Ottesen, B.,
T., Gerstenberg,
H. Ulrichsen,
T. Manthorpe,
J. Fahrenkrug, and
G. Wagner,
Vasoactive intestinal polypeptide (VIP) increases vaginal blood flow and inhibits smooth muscle activity in women.
Eur. J. Clin. Invest.
13:
321–324,
1983.
|
| 192. |
Ottesen, B.,
J‐J., Larsen,
J. Fahrenkrug,
M. Stjernquist, and
F. Sundler,
Distribution and motor effect of VIP in female genital tract.
Am. J. Physiol.
240
(Endocrinol. Metab. 3):
E32–E36,
1981.
|
| 193. |
Ottesen, B.,
H., Ulrichsen,
G. Wagner, and
J. Fahrenkrug,
Vasoactive intestinal polypeptide (VIP) inhibits oxytocin induced activity of the rabbit myometrium.
Acta Physiol. Scand.
107:
285–287,
1979.
|
| 194. |
Ottesen, B.,
G., Wagner, and
J. Fahrenkrug,
Vasoactive intestinal polypeptide (VIP) inhibits prostaglandin‐F2α,‐induced activity of the rabbit myometrium.
Prostaglandins
19:
427–435,
1980.
|
| 195. |
Pandian, M. R.,
A., Horwal, and
S. I. Said,
Radioimmunoassay of VIP in blood and tissues. In:
Vasoactive Intestinal Peptides, edited by
S. I. Said.
New York:
Raven,
1982,
p. 35–50.
|
| 196. |
Peatfield, A. C.,
P. J., Barnes,
C. Bratcher,
J. A. Nadel, and
B. Davis,
Vasoactive intestinal submucosal gland secretion in ferret.
Am. Rev. Respir. Dis.
128:
89–93,
1983.
|
| 197. |
Pederson, R.,
T., O'Dorisio,
B. Howe,
C. Mcintosh,
M. Mueller,
J. Brown, and
S. Cataland,
Vagal release of IR‐VIP and IR‐gastrin from the isolated perfused rat stomach.
Mol. Cell. Endocrinol.
23:
225–231,
1981.
|
| 198. |
Pelletier, G.,
R., Leclerc,
R. Puviani, and
J. M. Polak,
Electron immunocytochemistry in vasoactive intestinal peptide (VIP) in the rat brain.
Brain Res.
210:
356–360,
1981.
|
| 199. |
Polak, J. M., and
S. R. Bloom,
Localization and measurements of VIP in the genitourinary system of man and animals.
Peptides Fayetteville
5,
Suppl. 1:
225–230,
1984.
|
| 200. |
Polak, J. M.,
A. G. E., Pearse,
J.‐C. Garaud, and
S. R. Bloom,
Cellular localization of a vasoactive intestinal peptide in the mammalian and avian gastrointestinal tract.
Gut
15:
720–724,
1974.
|
| 201. |
Porter, J. P.,
I. A., Reid,
S. I. Said, and
W. F. Ganong,
Stimulation of renin secretion by vasoactive intestinal peptide.
Am. J. Physiol.
243
(Renal Fluid Electrolyte Physiol. 12):
F306–F310,
1982.
|
| 202. |
Porter, J. P.,
S. I., Said, and
W. F. Ganong,
Vasoactive intestinal peptide stimulates renin secretion in vitro: evidence for a direct action of the peptides on the renal juxtaglomerular cells.
Neuroendocrinology
36:
404–408,
1983.
|
| 203. |
Propert, L.,
J., De Mey, and
J. M. Polak,
Distinct subpopulations of enteric P‐type neurones contain substance P and vasoactive intestinal polypeptide.
Nature Lond.
294:
470–471,
1981.
|
| 204. |
Racusen, L. C., and
H. J. Binder,
Alteration of large intestinal electrolyte transport by vasoactive intestinal polypeptide in the rat.
Gastroenterology
73:
790–796,
1977.
|
| 205. |
Rattan, S.,
M., Grady, and
R. K. Goyal,
Vasoactive intestinal peptide causes peristaltic contractions in the esophageal body.
Life Sci.
30:
1557–1563,
1982.
|
| 206. |
Rattan, S.,
S. I., Said, and
R. K. Goyal,
Effect of vasoactive intestinal polypeptide (VIP) on the lower esophageal sphincter pressure (LESP).
Proc. Soc. Exp. Biol. Med.
155:
40–43,
1977.
|
| 207. |
Reinicke, M.,
P., Schlüter,
N. Yanaihara, and
W. G. Forsman,
VIP immunoreactivity in enteric nerves and endocrine cells of the vertebrate gut.
Peptides Fayetteville
2,
Suppl. 2:
149–156,
1981.
|
| 208. |
Rostene, W. H.,
Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP).
Prog. Neurobiol. Oxf.
22:
103–129,
1984.
|
| 209. |
Ryan, J., and
S. Cohen,
Effect of vasoactive intestinal polypeptide on basal and cholecystokinin‐induced gallbladder pressure.
Gastroenterology
73:
870–872,
1977.
|
| 210. |
Ryan, J. P., and
S. Ryave,
Effect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
Am. J. Physiol.
234
(Endocrinol. Metab. Gastrointest. Physiol. 3):
E44–E46,
1978.
|
| 211. |
Said, S. I.,
Vasoactive substances in the lung.
In: Proceedings of the Tenth Aspen Emphysema Conference, Aspen, Colorado, June 7–10.
USPHS Publ. 1787,
1967,
p. 223–228.
|
| 212. |
Said, S. I., and
G. R. Faloona,
Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery‐diarrhea syndrome due to pancreatic, bronchogenic and other tumors.
N. Engl. J. Med.
293:
155–160,
1975.
|
| 213. |
Said, S. I.,
S., Kitamura,
T. Yoshida,
J. Preskitt, and
L. D. Holden,
Humoral control of airways.
Ann. NY Acad. Sci.
221:
103–114,
1974.
|
| 214. |
Said, S. I., and
V. Mutt,
A peptide fraction of lung tissue with prolonged peripheral vasodilator activity.
Scand. J. Clin. Lab. Invest.
24,
Suppl. 107:
51–57,
1969.
|
| 215. |
Said, S. I., and
V. Mutt,
Long‐acting vasodilator peptide from lung tissue.
Nature Lond.
224:
699–700,
1969.
|
| 216. |
Said, S. I., and
V. Mutt,
Polypeptide with broad biological activity: isolation from small intestine.
Science Wash. DC
169:
1217–1218,
1970.
|
| 217. |
Said, S. I., and
V. Mutt,
Potent peripheral and splanchnic vasodilator peptide from normal gut.
Nature Lond.
225:
863–864,
1970.
|
| 218. |
Said, S. I., and
V. Mutt,
Isolation from porcine‐intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon.
Eur. J. Biochem.
28:
199–204,
1972.
|
| 219. |
Said, S. I., and
R. N. Rosenberg,
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue.
Science Wash. DC
192:
907–908,
1976.
|
| 220. |
Schaffalitzky De Muckadell, O. B.,
J. Fahrenkrug,
J. J. Holst, and
K. B. Lauritsen,
Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli.
Scand. J. Gastroenterol.
12:
793–797,
1977.
|
| 221. |
Schebalin, M.,
S. I., Said, and
G. M. Makhlouf,
Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide (VIP).
Am. J. Physiol.
232
(Endocrinol. Metab. Gastrointest. Physiol. 1):
E197–E200,
1977.
|
| 222. |
Schultzberg, M.,
C. F., Dreyfus,
M. Gershon,
T. Hökfelt,
R. P. Elde,
G. Nilsson,
S. Said, and
M. Goldstein,
VIP‐, enkephalin‐, substance P‐ and somatostatin‐like immunoreactivity in neurons intrinsic to the intestine: immunohistochemical evidence from organotypic tissue cultures.
Brain Res.
155:
239–248,
1978.
|
| 223. |
Schultzberg, M.,
T., Hökfelt,
G. Nilsson,
L. Terenius,
J. F. Rehfeld,
M. Brown,
R. Elde,
M. Goldstein, and
S. Said,
Distribution of peptide‐ and catecholamine‐containing neurons in the gastro‐intestinal tract of rat and guinea pig: immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine β‐hydroxylase.
Neuroscience
5:
689–744,
1980.
|
| 224. |
Schultzberg, M.,
T., Hökfelt,
L. Olson,
M. ÅLund,
G. Nilsson,
L. Terenius,
R. P. Elde,
M. Goldstein, and
S. Said,
Substance P, VIP, enkephalin and somatostatin immunoreactive neurons in intestinal tissue transplanted to the anterior eye chamber.
J. Autonom. Nerv. Syst.
1:
291–303,
1980.
|
| 225. |
Schwartz, C. J.,
D. V., Kimberg,
H. W. Sheerin,
M. Field, and
S. I. Said,
Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.
J. Clin. Invest.
54:
536–544,
1974.
|
| 226. |
Siegel, S. R.,
F. C., Brown,
D. O. Castell,
L. F. Johnson, and
S. I. Said,
Effects of vasoactive intestinal polypeptide (VIP) on lower esophageal sphincter in awake baboons. Comparison with glucagon and secretin.
Dig. Dis. Sci.
24:
345–349,
1979.
|
| 227. |
Smith, E. R.,
T. B., Miller,
M. M. Wilson, and
M. C. Appel,
Effects of vasoactive intestinal peptide on canine prostatic contraction and secretion.
Am. J. Physiol.
247
(Regulatory Integrative Comp. Physiol. 16):
R701–R708,
1984.
|
| 228. |
Smitherman, T. C.,
H., Sakio,
A. M. Geumei,
T. Yoshida,
M. Oyamada, and
S. I. Said,
Coronary vasodilator action of VIP. In:
Vasoactive Intestinal Peptides, edited by
S. I. Said.
New York:
Raven,
1982,
p. 169–176.
|
| 229. |
Souquet, J. C.,
J. P., Riou,
M. Beylot,
J. A. Chayvialla, and
R. Mornex,
Effects of VIP on glucose and lactate metabolism in isolated rat liver cells.
FEBS Lett.
145:
115–120,
1982.
|
| 230. |
Ström, C.,
J. M., Lundberg,
H. Ahlman,
A. Dahlstrom,
J. Fahrenkrug, and
T. Hökfelt,
On the VIPergic innervation of the uterotubal junction.
Acta Physiol. Scand.
111:
213–215,
1981.
|
| 231. |
Sundler, F.,
J., Alumets,
R. Håkanson,
J. Fahrenkrug, and
O. B. Schaffalitzky De Muckadell,
Peptidergic (VIP) nerves in the pancreas.
Histochemistry
55:
173–176,
1978.
|
| 232. |
Sundler, F.,
J., Alumets,
R. Håkanson,
S. Ingemansson,
J. Fahrenkrug, and
O. Schaffalitzky De Muckadell,
VIP innervation of the gallbladder.
Gastroenterology
72:
1375–1377,
1977.
|
| 233. |
Suzuki, Y.,
D., Mcmaster,
K. Lederis, and
O. P. Rorstad,
Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries.
Brain Res.
322:
9–16,
1984.
|
| 234. |
Szecowka, J.,
P. E., Lins,
K. Tatemoto, and
S. Efendic,
Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.
Endocrinology
112:
1469–1473,
1983.
|
| 235. |
Szecowka, J.,
E., Sandberg, and
S. Efendic,
The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
Diabetologia
19:
137–142,
1980.
|
| 236. |
Szecowka, J.,
K., Tatemoto,
V. Mutt, and
S. Efendic,
Interaction of a newly isolated intestinal polypeptide (PHI) with glucose and arginine to effect the secretion of insulin and glucagon.
Life Sci.
26:
435–438,
1980.
|
| 237. |
Tatemoto, K.,
PHI—a new brain‐gut peptide.
Peptides NY
5:
151–154,
1984.
|
| 238. |
Tatemoto, K.,
M., Carlquist,
T. J. Mcdonald, and
V. Mutt,
Isolation of a brain peptide, identical to the intestinal PHI (peptide HI).
FEBS Lett.
153:
248–252,
1983.
|
| 239. |
Tatemoto, K.,
H., Jörnvall,
T. J. Mcdonald,
M. Carlquist,
W. L. W. Go,
C. Johansson, and
V. Mutt,
Isolation and primary structure of human PHI (peptide HI).
FEBS Lett.
174:
258–261,
1984.
|
| 240. |
Tatemoto, K., and
V. Mutt,
Chemical determination of polypeptide hormones.
Proc. Natl. Acad. Sci. USA
75:
4115–4119,
1978.
|
| 241. |
Tatemoto, K., and
V. Mutt,
Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides.
Nature Lond.
285:
417–418,
1980.
|
| 242. |
Tatemoto, K., and
V. Mutt,
Isolation and characterization of the intestinal peptide porcine PHI (PHI‐27), a new member of the glucagon‐secretin family.
Proc. Natl. Acad. Sci. USA
78:
6603–6607,
1981.
|
| 243. |
Terubayashi, H.,
H., Okamura,
H. Fujisawa,
M. Itoi,
N. Yanaihara, and
Y. Ibata,
Postnatal development of vasoactive intestinal polypeptide immunoreactive amacrine cells in rat retina.
Neurosci. Lett.
33:
259–264,
1982.
|
| 244. |
Terubayashi, H.,
T., Tuto,
K. Fukui,
H. L. Obata,
H. Okamura,
H. Fujisawa,
M. Itoi,
C. Yanaihara,
N. Yanaihara, and
Y. Ibata,
VIP (vasoactive intestinal polypeptide)‐like immunoreactive amacrine cells in the retina of the rat.
Exp. Eye Res.
36:
743–749,
1983.
|
| 245. |
Thulin, L., and
P. Olsson,
Effects of intestinal peptide mixture G2 and vasoactive intestinal polypeptide VIP on splanchnic circulation in the dog.
Acta. Chir. Scand.
139:
691–697,
1973.
|
| 246. |
Toccafondi, R. S.,
M. L., Brandi, and
A. Melander,
Vasoactive intestinal peptide stimulation of human thyroid cell function.
J. Clin. Endocrinol. Metab.
58:
157–160,
1984.
|
| 247. |
Tornqvist, K.,
R., Uddman,
F. Sundler, and
B. Ehinger,
Somatostatin and VIP neurons in the retina of different species.
Histochemistry
76:
137–152,
1982.
|
| 248. |
Uddman, R.,
J., Alumets,
O. Densert,
M. Ekelund,
R. Håkanson,
I. Loren, and
F. Sundler,
Innervation of the feline eustachian tube.
Ann. Otol. Rhinol. Laryngol.
88:
557–561,
1979.
|
| 249. |
Uddman, R.,
J., Alumets,
O. Densert,
R. Håkanson, and
F. Sundler,
Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall.
Acta Otolaryngol.
86:
443–448,
1978.
|
| 250. |
Uddman, R.,
J., Alumets,
L. Edvinsson,
R. Håkanson, and
F. Sundler,
Peptidergic (VIP) innervation of the esophagus.
Gastroenterology
75:
5–8,
1978.
|
| 251. |
Uddman, R.,
J., Alumets,
L. Edvinsson,
R. Håkanson, and
F. Sundler,
VIP nerve fibres around peripheral blood vessels.
Acta Physiol. Scand.
112:
65–70,
1981.
|
| 252. |
Uddman, R.,
J., Alumets,
R. Håkanson,
I. Loraine, and
F. Sundler,
Vasoactive intestinal peptide (VIP) occurs in nerves of the pineal gland.
Experientia Basel
36:
119–120,
1980.
|
| 253. |
Uddman, R.,
J., Fahrenkrug,
L. Malm,
J. Alumets,
R. Håkanson, and
F. Sundler,
Neuronal VIP in the salivary glands: distribution and release.
Acta Physiol. Scand.
110:
31–38,
1980.
|
| 254. |
Uddman, R.,
L., Malm, and
J. Fahrenkrug,
VIP increases in basal blood during stimulation of the vidian nerve.
Acta Otolaryngol.
91:
135–138,
1981.
|
| 255. |
Uddman, R.,
L. Malm, and
F. Sundler.
The origin of vasoactive intestinal polypeptide (VIP) nerves in the feline nasal mucosa.
Acta Otolaryngol.
89:
152–156,
1980.
|
| 256. |
Vagne, M., and
V. Toitskaja,
Effect of secretin, glucagon and VIP on gallbladder contraction.
Digestion
14:
62–67,
1976.
|
| 257. |
Venugopalan, C. S.,
S. I., Said, and
J. M. Drazen,
Effect of vasoactive intestinal peptide on vagally mediated tracheal pouch relaxation.
Respir. Physiol.
56:
205–216,
1984.
|
| 258. |
Villar, H. V.,
H. R., Fender,
P. L. Rayford,
S. R. Bloom,
N. I. Ramus, and
J. C. Thompson,
Suppression of gastrin release and gastric secretion by gastric inhibitory polypeptide (GIP) and vasoactive intestinal polypeptide (VIP).
Ann. Surg.
184:
97–102,
1976.
|
| 259. |
Waldman, D. B.,
J. D., Gardner,
A. M. Zfass, and
G. M. Makhlouf,
Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity.
Gastroenterology
73:
518–523,
1977.
|
| 260. |
Wei, E. P.,
H. A., Kontos, and
S. I. Said,
Mechanism of action of vasoactive intestinal polypeptide on cerebral arterioles.
Am. J. Physiol.
239:
(Heart Circ. Physiol. 8): H765–H768,
1980.
|
| 261. |
Weihe, E.,
M., Reinecke, and
W. G. Forssman,
Distribution of vasoactive intestinal polypeptide‐like immunoreactivity in the mammalian heart.
Cell Tissue Res.
236:
527–540,
1984.
|
| 262. |
Wharton, J.,
J. M., Polak,
M. G. Bryant,
S. Van Noorden,
S. R. Bloom, and
A. G. E. Pearse,
Vasoactive intestinal polypeptide (VIP)‐like immunoreactivity in salivary glands.
Life Sci.
25:
273–280,
1979.
|
| 263. |
Willis, E. A.,
B., Ottesen,
G. Wagner,
F. Sundler, and
J. Fahrenkrug,
Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection.
Life Sci.
33:
383–391,
1983.
|
| 264. |
Wood, C. L., and
J. J. Blum,
Effects of vasoactive intestinal polypeptide on glycogen metabolism in rat hepatocytes.
Am. J. Physiol.
242
(Endocrinol. Metab. 5):
E262–E272,
1982.
|
| 265. |
Yanaihara, N.,
K. Nokihara,
C. Yanaihara,
T. Iwanaga, and
T. Fujita.
Immunocytochemical demonstration of PHI and its co‐existence with VIP in intestinal nerves of the rat and pig.
Arch. Histol. Jpn.
46:
575–581,
1983.
|
| 266. |
Yanaihara, N.,
M., Sakagami,
H. Sato,
K. Yamamoto,
T. Hashimoto,
T. Yanaihara,
Z. Ito,
K. Yamaguchi, and
K. Abe,
Immunological aspects of secretin, substance P and VIP.
Gastroenterology
72:
803–810,
1977.
|
| 267. |
Yanaihara, N.,
C. Yanaihara,
K. Nokihara,
K. Iguchi,
S. Fukata,
M. Tanaka,
Y. Yamamoto, and
T. Mochizuki.
Immunochemical study on PHI/PHM with use of synthetic peptides.
Peptides Fayetteville
5:
247–254,
1984.
|
| 268. |
Yiangou, Y.,
N. D. Christopides,
J. Gu,
P. J. Piper,
J. M. Polak, and
S. R. Bloom.
PHI‐like immunoreactivity in the gallbladder and in vitro effect of porcine PHI on smooth‐muscle of the gallbladder.
FEBS Lett.
175:
307–312,
1984.
|
